GSK and Vir take COVID-19 antibody therapy into clinicGlaxoSmithKline and US-based Vir Biotechnology are to trial a new therapy for COVID-19 based on an antibody designed Share XGSK and Vir take COVID-19 antibody therapy into clinichttps://pharmaphorum.com/news/gsk-and-vir-take-covid-19-antibody-therapy-into-clinic/
